Grantham, Mayo, Van Otterloo & Co (GMO)’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,800
Closed -$209K 754
2022
Q4
$209K Buy
+10,800
New +$209K ﹤0.01% 675